JSPR
Jasper Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 6, 2026 3:59:35 PM EST
16.90USD+20.063%(+2.82)63,386
Loading…
Loading…
557.35M
Healthcare
Biotechnology
HQ
Redwood City, CA, USA
Previous Close
$14.08
Beta
-63.37
52-Week High
$14.94 2026-11-05
52-Week Low
$0.32 2026-06-29
SMA 50
$0.86
SMA 200
$0.90
Avg. Vol 10D
474,243
Avg. Vol 30D
401,427
Avg. Vol 90D
1.09M
Relative Vol
0.15
33.27M
29.82M
89.62%
6,474,345
21.71%
18.53
59%/41%
20.45%
10.57%
12.5600%
2,313
18,802
94,235
Nov 9, 2026 (3d)
Jan 4, 2024 · 1-for-10 (reverse)
-31.8M
-1.23
-255.05
Nov 4, 2026
Jasper Therapeutics to execute 1-for-30 reverse stock split · 
Seeking Alpha
Jasper Therapeutics Announces 1-for-30 Reverse Stock Split · 
GlobeNewswire Inc.
Oct 14, 2026
Oct 7, 2026
JSPR Profile
jasper therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. jasper's lead compound, jsp191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
JSPR Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.52 | 2026-10-30 | +3119.91% | -479.270 |
| 1M | 0.56 | 2026-10-06 | +2890.54% | -360.124 |
| 3M | 0.65 | 2026-08-06 | +2492.48% | -250.537 |
| 6M | 0.95 | 2026-05-06 | +1669.12% | -122.745 |
| 1Y | 1.83 | 2025-11-06 | +815.30% | -63.369 |
| 2Y | 23.70 | 2024-11-06 | -29.32% | — |
| 5Y | 92.70 | 2021-11-05 | -81.93% | -7.041 |
JSPR Stock Summary
Jasper Therapeutics, Inc. Common Stock (NASDAQ:JSPR) stock price today is $16.75, and today's volume is 60,593. JSPR is up 18.997% today. The 30 day average volume is 401,427. JSPR market cap is $557.35M with 33.27M shares outstanding.